Standout Papers

PI3K Inhibitors in Cancer: Clinical Implications and Adverse Effects 2021 2026 2022 2024184
  1. PI3K Inhibitors in Cancer: Clinical Implications and Adverse Effects (2021)
    Rosalin Mishra, Hima Patel et al. International Journal of Molecular Sciences

Immediate Impact

63 standout
Sub-graph 1 of 22

Citing Papers

Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer
2024 Standout
Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update
2024 Standout
4 intermediate papers

Works of Hima Patel being referenced

PI3K Inhibitors in Cancer: Clinical Implications and Adverse Effects
2021 Standout
Current Advances in the Treatment of BRAF-Mutant Melanoma
2020

Author Peers

Author Last Decade Papers Cites
Hima Patel 267 367 82 122 19 652
Rosalin Mishra 334 404 128 136 19 698
Kelly L. Mueller 255 300 45 130 14 672
D. Gandara 370 474 41 199 26 821
Sabine Strommer 209 428 42 108 25 758
Tsutomu Koide 269 299 49 167 19 676
Julia Kirshner 373 364 164 75 29 835
Grit S. Herter-Sprie 302 342 46 102 14 659
Linda Simpson‐Herren 282 321 87 121 29 782
Manuel Sequeira 209 610 54 216 21 752
Qingyang Gu 228 341 58 111 26 636

All Works

Loading papers...

Rankless by CCL
2026